Phreesia, which provides a patient-intake software platform for healthcare providers, raised $167 million by offering 9.3 million shares at $18, above the range of $15 to $17. Phreesia plans to list on the NYSE under the symbol PHR. J.P. Morgan, Wells Fargo Securities, William Blair, Allen & Company and Piper Jaffray acted as lead managers on the deal.
